Thomas Litman Selected Research

Thomas Litman Research Topics

Disease

28	Neoplasms (Cancer) 10/2022 - 02/2002
7	Mycosis Fungoides 10/2022 - 12/2014
7	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 10/2021 - 11/2011
7	Breast Neoplasms (Breast Cancer) 01/2019 - 02/2002
6	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2022 - 06/2010
6	Inflammation (Inflammations) 01/2022 - 11/2011
5	Atopic Dermatitis (Atopic Eczema) 01/2022 - 12/2014
3	Skin Diseases (Skin Disease) 05/2022 - 11/2011
3	Neoplasm Metastasis (Metastasis) 10/2015 - 07/2012
3	Colonic Neoplasms (Colon Cancer) 09/2012 - 07/2005
2	Eczema 11/2022 - 02/2022
2	Dermatitis 01/2022 - 11/2011
2	Disease Progression 01/2021 - 07/2012
2	T-Cell Lymphoma (Lymphoma, T Cell) 07/2015 - 12/2014
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 07/2015 - 11/2011
1	Contact Dermatitis (Eczema, Contact) 02/2022
1	Colorectal Neoplasms (Colorectal Cancer) 12/2021
1	Asthma (Bronchial Asthma) 01/2020
1	Atrophy 12/2017
1	Hypersensitivity (Allergy) 10/2017
1	Actinic Keratosis 01/2016
1	Atherosclerosis 10/2015
1	Birth Weight (Birth Weights) 02/2015
1	Type 2 Diabetes Mellitus (MODY) 02/2015
1	Ductal Carcinoma 06/2014
1	Rectal Neoplasms (Rectal Cancer) 09/2012
1	Genomic Instability 12/2011
1	Hypoxia (Hypoxemia) 12/2011
1	Ehrlich Tumor Carcinoma 12/2011
1	Infections 09/2011
1	Teratoma (Teratoid Tumor) 06/2009

Drug/Important Bio-Agent (IBA)

22	MicroRNAs (MicroRNA)IBA 10/2022 - 09/2008
8	Proteins (Proteins, Gene)FDA Link 09/2020 - 02/2002
5	Pharmaceutical PreparationsIBA 12/2014 - 04/2004
3	RNA (Ribonucleic Acid)IBA 05/2022 - 06/2009
3	Biomarkers (Surrogate Marker)IBA 02/2022 - 01/2012
3	Mitoxantrone (Novantrone)FDA LinkGeneric 07/2005 - 02/2002
2	Anti-Bacterial Agents (Antibiotics)IBA 10/2021 - 01/2019
2	Interleukin-13IBA 04/2021 - 01/2020
2	ParaffinIBA 03/2021 - 01/2014
2	Messenger RNA (mRNA)IBA 01/2020 - 09/2008
2	romidepsin (FK228)FDA Link 07/2015 - 12/2014
2	Histone Deacetylase InhibitorsIBA 12/2014 - 09/2008
2	CytokinesIBA 12/2014 - 09/2011
2	EnzymesIBA 09/2008 - 06/2007
2	Complementary DNA (cDNA)IBA 09/2008 - 07/2005
1	16S Ribosomal RNAIBA 11/2022
1	Irritants (Vesicants)IBA 02/2022
1	LipopolysaccharidesIBA 01/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2022
1	Imiquimod (Aldara)FDA LinkGeneric 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	LigandsIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	STAT5 Transcription FactorIBA 10/2021
1	Enterotoxins (Enterotoxin)IBA 10/2021
1	tralokinumabIBA 04/2021
1	Formaldehyde (Formol)FDA Link 03/2021
1	ThioredoxinsIBA 09/2020
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 09/2020
1	Interleukin-5 (Interleukin 5)IBA 01/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2020
1	secukinumabIBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2019
1	GlucocorticoidsIBA 12/2017
1	Extracellular Matrix ProteinsIBA 12/2017
1	diphenylcyclopropenoneIBA 10/2017
1	OvalbuminIBA 01/2017
1	Filaggrin ProteinsIBA 01/2017
1	3-ingenyl angelateIBA 01/2016
1	E-SelectinIBA 10/2015
1	ProteomeIBA 10/2015
1	Glucose (Dextrose)FDA LinkGeneric 02/2015
1	Insulin (Novolin)FDA Link 02/2015
1	Vorinostat FDA Link 12/2014
1	AnnexinsIBA 12/2014
1	imidazole mustard (BIC)IBA 06/2013
1	Biological ProductsIBA 09/2012
1	Estrogen ReceptorsIBA 01/2012
1	Tamoxifen FDA LinkGeneric 01/2012
1	InterferonsIBA 09/2011
1	Interferon Type IIBA 09/2011
1	Interleukin-15 (Interleukin 15)IBA 09/2011
1	Valproic Acid (Depakote)FDA LinkGeneric 09/2008
1	belinostatIBA 09/2008
1	Protein Isoforms (Isoforms)IBA 09/2008
1	3' Untranslated Regions (3' UTR)IBA 09/2008
1	DNA (Deoxyribonucleic Acid)IBA 06/2007
1	XenobioticsIBA 04/2006
1	Cytostatic AgentsIBA 07/2005
1	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2005

Therapy/Procedure

8	Therapeutics 01/2021 - 03/2005
2	Drug Therapy (Chemotherapy) 07/2005 - 04/2004
1	Subcutaneous Injections 01/2022
1	Stents 12/2021
1	Precision Medicine 05/2019
1	Lasers (Laser) 01/2015
1	Traction 12/2014
1	Duration of Therapy 12/2014